Physician profile
Michael J Marcus
NPI 1720064165
$1,895.86
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $262 · 2021: $228 · 2022: $27.81 · 2023: $131 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $498.23 | 2019 | |
| Integra Lifesciences Corporation | $236.90 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Wright Medical Technology, INC. | $221.22 | 2019 | |
| Paragon 28, INC. | $219.04 | 2019 | |
| Smith+Nephew, INC. | $216.05 | 2019-2024 | Collagenase Santyl |
| Treace Medical Concepts, INC. | $117.67 | 2023 | |
| Stryker Corporation | $93.67 | 2020 | |
| Amniox Medical, INC. | $89.40 | 2020 | |
| Zimmer Biomet Holdings, INC. | $71.84 | 2021 | |
| Siemens Medical Solutions USA, INC. | $70.61 | 2019 | |
| Cardiovascular Systems INC. | $28.10 | 2021 | |
| Merck Sharp & Dohme LLC | $19.92 | 2019 | |
| Tactile Systems Technology INC | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.